会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • X-linked adrenoleukodystrophy gene and corresponding protein
    • X连锁肾上腺脑白质营养不良基因和相应的蛋白质
    • US5869039A
    • 1999-02-09
    • US479403
    • 1995-06-07
    • Jean-Louis MandelPatrick AubourgJean MosserClaude Sarde
    • Jean-Louis MandelPatrick AubourgJean MosserClaude Sarde
    • A61K38/00C07K14/47C07K14/705C12N9/00G01N33/68A01N63/00A61K48/00
    • C12N9/93C07K14/47C07K14/705G01N33/6893A61K38/00C12N2799/027
    • A method for the treatment of adrenoleukodystrophy or adrenomyeloneuropathy, in which there is administered to a human patient in need of the same an effective amount of hematopoietic cells modified ex vivo by infection with a retroviral vector containing a nucleic acid fragment comprising a sequence as represented on FIG. 2 (SEQ. ID No: 1) or FIG. 6 (SEQ. ID. No: 4-17) or FIG. 7 (SEQ. ID No: 18-23). Also, human hematopoietic cells can be treated ex vivo to correct the content of very long chain fatty acids in them, by providing human hematopoietic cells of a patient affected by adrenoleukodystrophy or adrenomyeloneuropathy, and infecting them ex vivo with a retroviral vector containing, operably linked to a promoter, a nucleic acid fragment as above. The expression of the nucleic acid in the hematopoietic cells corrects the content of very long chain fatty acids in the hematopoietic cells.
    • 一种用于治疗肾上腺脑白质营养不良或肾上腺皮质神经病的方法,其中向需要相同有效量的造血细胞的人类患者施用有效量的造血细胞,所述造血细胞通过用含有如下所示序列的核酸片段的逆转录病毒载体的感染进行感染 图。 2(SEQ ID NO:1)或图2。 6(SEQ ID NO:4-17)或图6。 7(SEQ ID NO:18-23)。 此外,通过提供受肾上腺脑白质营养不良或肾上腺皮质神经病变影响的患者的人造血细胞,并使用含有可操作地连接的逆转录病毒载体感染它们,离体处理人类造血细胞以校正其中的非常长链脂肪酸的含量 启动子,如上所述的核酸片段。 造血细胞中核酸的表达校正了造血细胞中非常长链脂肪酸的含量。